Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4).

Source:http://linkedlifedata.com/resource/pubmed/id/19788238

J. Med. Chem. 2009 Oct 22 52 20 6433-46

Download in:

View as

General Info

PMID
19788238